4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-26-000053
Options or other derivatives
- President and CEO acquired 1,951,703 shares (grant or award)
- President and CEO returned 1,951,703 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Coulie Bernard President and CEO | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −146,841 | 0 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +146,841 | 146,841 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −327,262 | 0 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +327,262 | 327,262 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −250,000 | 0 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −440,000 | 0 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +440,000 | 440,000 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −206,300 | 0 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +206,300 | 206,300 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −256,300 | 0 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +256,300 | 256,300 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −325,000 | 0 | D | ||
| Coulie Bernard President and CEO | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | D | ||
Loading xslF345X06/wk-form4_1776458555.xml…